Nonsynaptic Noradrenaline Release in Neuro-Immune Responses

被引:0
作者
E. S. Vizi
I. J. Elenkov
机构
[1] Semmelweis University,Department of Pharmacology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Department of Pharmacology and Pharmacotherapy
[2] Georgetown University Medical Center,Division of Rheumatology, Immunology and Allergy
来源
Acta Biologica Hungarica | 2002年 / 53卷
关键词
Immune response; sympathetic outflow; cytokines; nonsynaptic;
D O I
暂无
中图分类号
学科分类号
摘要
Evidence has recently been obtained that the branches of the autonomic nervous system, mainly, the sympathetic [25], regulate cytokine production. Not only the primary (thymus, bone marrow) and secondary (spleen, tonsils, and lymph nodes) lymphoid organs, but also many other tissues are involved in immune responses and are heavily influenced by noradrenaline (NA) derived from varicose axon terminals of the sympathetic nervous system [25, 100]. Besides NA released from nonsynaptic varicosities of noradrenergic terminals [92], circulating catecholamines (adrenaline, dopamine, NA) are also able to influence immune responses, the production of pro- and anti-inflammatory cytokines by different immune cells. The sympathetic nervous system (catecholamines) and the hypothalamic-pituitary-adrenal (HPA) axis (cortisol) are the major integrative and regulatory components of different immune responses. In our laboratory convincing evidence has been obtained that NA released non-synaptically [90, 92] from sympathetic axon terminals and enhanced in concentration in the close proximity of immune cells is able to inhibit production of proinflammatory (TNF-α, IFN-γ, IL-12, IL-1) and increase antiinflammatory cytokines (IL-10) in response to LPS [25, 91], indicating a fine-tuning control of the production of TNF-α and other cytokines by sympathetic innervation under stressful conditions. This effects are mediated via β2-adrenoceptors expressed on immune cells and coupled to cAMP levels.
引用
收藏
页码:229 / 244
页数:15
相关论文
共 409 条
[1]  
Abraham E(1995)Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group JAMA 273 934-941
[2]  
Wunderink R(1991)A lipopolysaccharide (LPS)-resistant mutant isolated from a macrophagelike cell line, J774. 1, exhibits an altered activated-macrophage phenotype in response to LPS Infect Immun. 59 2166-2174
[3]  
Silverman H(2001)Inflammatory neurodegeneration mediated by nitric oxide fromactivated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity J. Neurosci. 21 6480-6491
[4]  
Perl T M(1990)Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA 87 620-624
[5]  
Nasraway S(1994)Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration Prog. Brain. Res. 103 371-380
[6]  
Levy H(1997)Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes Brain Research 761 236-243
[7]  
Bone R(2001)Immunological aspects of microglia: relevance to Alzheimer’s disease Neurochem. Int. 39 381-391
[8]  
Wenzel R P(1996)Immune-neuro-endocrine interactions: facts and hypothesis Endocrine Rev. 17 64-102
[9]  
Balk R(1991)The pathogenesis of sepsis Ann. Intern. Med. 115 457-469
[10]  
Allred R(1992)Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1644-1655